This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Sorting Out Their Origins

Adi F. Gazdar, MD

JAMA. 1997;277(2):154-155.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Most recipients of solid organ transplantation receive immunosuppressive therapy for prolonged periods and are at greatly increased risk for tumor development. These tumors have 4 origins: (1) recurrence of malignancies existing in the recipient prior to transplantation; (2) malignancies of recipient origin arising de novo after transplantation; (3) tumors of donor origin arising de novo in the transplanted organ; and (4) preexisting tumors of donor origin transmitted inadvertently to the recipient via the transplanted organ. While in the majority of cases the presumed origin of the tumors can be surmised correctly, the correct categorization of some may be difficult or controversial. In this issue of THE JOURNAL, Loh et al¹ describe the use of molecular markers to identify the donor derivation of a metastatic prostatic carcinoma in a recipient following heart transplantation. A prostatic carcinoma was identified in the donor at autopsy after the transplant procedure had been initiated . . . [Full Text PDF of this Article]

Author Affiliations
From the Hamon Center for Therapeutic Oncology and Department of Pathology, University of Texas Southwestern Medical Center, Dallas.

Footnotes
Reprints: Adi F. Gazdar, MD, Hamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?